New Study Finds Lee Silverman Voice Treatment Superior for Parkinson's Speech Therapy

Clinical trial shows LSVT LOUD outperforms NHS standard care in improving communication for Parkinson's patients.

LSVT LOUD significantly reduces voice handicap scores compared to NHS therapy or no treatment.
The intensive four-week program includes face-to-face or remote sessions and home-based practice.
NHS speech therapy showed no evidence of benefit over no treatment in the trial.
The study suggests the need for better resource allocation for Parkinson's speech therapy.
Researchers call for further investigation into optimizing therapy delivery for broader patient access.